We therefore examined the expression of components of the pyruvate dehydrogenase complex (PDC), and found that the third component of the complex, dihydrolipoyl dehydrogenase (DLD), is significantly reduced in bladder cancer (p < 10-7; Table 1). The gene discussed is DLD; the disease is urinary bladder carcinoma.